Terms ending in 2041
Every in-force patent on Translate Bio, Inc.'s record whose computed term ends in 2041, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,410,422 | Methods For Purification of Messenger RNA In force · High confidence | Translate Bio, Inc. | In force | High confidence | |
| US 12,053,551 | Process of Preparing Mrna-Loaded Lipid Nanoparticles In force · High confidence | Translate Bio, Inc. | In force | High confidence | |
| US 12,734,253 | Processes of Preparing Mrna-Loaded Lipid Nanoparticles In force · Medium confidence | Translate Bio, Inc. | In force | Medium confidence | |
| US 11,969,480 | Processes of Preparing Mrna-Loaded Lipid Nanoparticles In force · High confidence | Translate Bio, Inc. | In force | High confidence | |
| US 12,778,891 | Multi-Peg Lipid Compounds In force · High confidence | Translate Bio, Inc. | In force | High confidence | |
| US 11,975,110 | Cationic Polymers In force · High confidence | Translate Bio, Inc. | In force | High confidence | |
| US 12,076,439 | Thioester Cationic Lipids In force · High confidence | Translate Bio, Inc. | In force | High confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.